Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2001-10-05
2010-11-23
Duffy, Patricia A (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S197110, C424S256100, C530S350000, C530S324000, C530S325000, C530S326000
Reexamination Certificate
active
07838003
ABSTRACT:
The invention provides BASB205 polypeptides and polynucleotides encoding BASB205 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
REFERENCES:
patent: 5888517 (1999-03-01), Forsgren
patent: WO 96/33276 (1996-10-01), None
Feng et al (Infection and Immunity, 64(1):363-365, 1996).
Ellis, R.W. (Chapter 29 of “Vaccines” [Plotkin, S.A. et al. (eds) published by W. B. Saunders company (Philadelphia) in 1988.
Kaumaya et al (Peptides: Design, Synthesis, and Biological Activity, Birkauser Boston, 1994 (pp. 133-164).
Kurono et al, (Laryngoscope 106:614-618, 1996).
Yang et al Infection and Immunity 66(5):1973-1980, 1998).
Green et al , Infection and Immunity 61(5):1950-1957, 1993).
Lerner et al (Nature 299:592-596, 1982).
Palfreyman et al (Journal of Immunological methods 75:383-393, 1984).
Campbell, (Monoclonal Antibody Technology, Elsevier Science Publishers B.V., 1986, p. 29, section 1.3.4.).
Harlow et al (Antibodies: A Laboratory Manual, Cold Spring Harbor Press, 1989, Chapter 6, pp. 139-243, 1989 and Chapter 5, pp. 83-137).
Sambrook et al (Molecular Cloning A Laboratory Manual, Cold Sprin Harbor Press, vol. 3, Ch 17, pga 17.1-17-44, 1989).
Stenesh, Dictionary of Biochemistry and Molecular Biology p. 97 (John Wiley & Sons, 2d ed. 1989)).
Herbert et al eds., The Dictionary of Immunology, Academic Press, 1995, definition of vaccine.
Kimball, Introduction to Immunology, Macmillian Publishing Company 1986, p. 30-31.
Stedman's Medical Dictionary 27th Edition, 2002, printed Mar. 23, 2009 from the web.
McGuinness et al. (Mol. Microbiol. 7: 505-514, Feb. 1993).
McGuinness et al. (Lancet 337: 514-517, Mar. 1991).
Houghten et al. (New Approaches to Immunization, Vaccines86, Cold Spring Harbor Laboratory, p. 21-25, 1986).
Greenspan et al. (Nature Biotechnology 7: 936-937, 1999).
Greenbaum et al, Journal of Molecular Recognition, 20(2):75-82, 2007.
Blythe et al, Protein Science 14:246-248, 2005.
Ellis et al, in New Bacterial Vaccines, 2003, pp. 229-259.
Herbert et al eds, The Dictionary of Immunology, Academic Press, 1995 pp. 88-89.
The University of Buffalo web site, 2009.
Fleischmann, R D, et al. “Haemophilus influenzae Rd section 153 of 163 of the complete genome.” Aug. 9, 1995.
Fleischmann, R. et al. “Probable lipoprotein nlpC homolog precursor.” Nov. 1, 1995.
Fleischmann, R D, et al. “Whole-Genome Random Sequencing and Assembly of Haemophilus lnfluenzae Rd” Science, vol. 269(5223), Jul. 28, 1995.
Tatusov, R. L., et al. “Metablolism and Evolution of Haemophilus lnfluenzae Deduced from a Whole-Genome Comparison withEscherichia coli” Current Biology, Current Science, vol. 6, No. 3. Mar. 1, 1996 pp. 279-291.
Klein, 1994, “Otitis Media,”Clinical Infectious Diseases19:823-833.
Murphy, 1996, “Branhamella catarrhalis: Epidemiology, Surface Antigenic Structure, and Immune Response,”Microbiological Reviews60(2):267-279.
Dickinson et al., 1988, “Restriction Fragment Mapping ofBranhamella catarrhalis: A New Tool for Studying the Epidemiololgy of This Middle Ear Pathogen,”The Journal of Infectious Diseases158(1):205-208.
Fadan et al., 1991, “Nasopharyngeal Flora in the first Three Years of Life in Normal and Otitis-Prone Children,”Ann Otol Rhinol Laryngol100:612-615.
Fadan et al., 1994, “Epidemiology ofMoraxella catarrhalisin Children during the first 2 Years of Life: Relationship to Otitis Media,”The Journal of Infectious Diseases169:1312-1317.
Leach et al., 1994, “Bacterial Colonization of the Nasopharynx Predicts very early onset and Persistence of Otitis Media in Australian Aboriginal Infants,”Pediatric Infectious Disease Journal13(11):983-989.
Prellner et al., 1984, “Nasopharyngeal Carriage of Bacteria in Otitis-Prone and Non-otitis-prone Children in Day-Care Centres,”Acta Otolaryngol(Stockh) 98:343-350.
Stenfors et al., 1992, “Abundant Attachment of Bacteria to Nasopharyngeal Epithelium in Otitis-Prone Children,”The Journal of Infectious Diseases165:1148-1150.
Stenfors et al., 1993, “Secretory IgA-, IgG- and C3b-coated Bacteria in the Nasopharynx of Otitis-Prone and Non-Otitis-Prone Children,”Acta Otolaryngol(Stockh) 113:191-195.
Read et al., 1991, “Interaction of Nontypable Haemophilus influenzae with Human Respiratory Mucosa In Vitro,”The Journal of Infectious Diseases163:549-558.
Brinton et al., 1989, “Design and development of pilus vaccines for Haemophilus influenzae diseases,”Pediatric Infectious Disease Journal8(1):S54-S61.
Kar et al., 1990, “Cloning and Expression inEscherichia coliof LKP Pilus Genes from a Nontypeable Haemophilus influenzae Strain,”Infection and Immunity58(4):903-908.
Gildorf et al., 1992, “Comparison of Hemagglutinating Pili of Haemophilus influenzae Type b with Similar Structures of Nontypeable H. influenzae,”Infection and Immunity60(2):374-379.
St. Geme et al., 1991, “Surface Structures and Adherence Properties of Diverse Strains of Haemophilus influenzae Biogroup aegyptius,”Infection and Immunity59(10):3366-3371.
St. Geme et al., 1993, “Isolation, Expression, and Nucleotide Sequencing of the Pilin Structural Gene of the Brazilian Purpuric Fever Clone of Haemophilus influenzae Biogroup aegyptius,”Infection and Immunity61(5):2233-2237.
St. Geme et al., 1993, “High-Molecular-weight proteins of nontypable Haemophilus influenzae mediate attachment to human epithelial cells,”Proc. Natl. Acaad. Sci. USA90:2875-2879.
Barenkamp et al., 1996, “Identification of a second family of high-molecular-weight adhesion proteins expressed by non-typable Haemophilus influenzae,”Molecular Microbiology19(6):1215-1223.
St. Geme et al., 1996, “Characterization of the Genetic Locus Encoding Haemophilus influenzae Type b Surface Fibrils,”Journal of Bacteriology178(21):6281-6287.
St. Geme et al., 1994, “A Haemophilus influenzae IgA protease-like protein promotes intimate interaction with human epithelial cells,”Molecular Microbiology14(2):217-233.
Loeb, 1987, “Protection of Infant Rats from Haemophilus influenzae Type b Infection by Antiserum to Purified Outer Membrane Protein a,”Infection and Immunity55(11):2612-2618.
Munson et al., 1983, “Purification and Comparison of Outer Membrane Protein P2 from Haemophilus influenzae Type b Isolates,”J. Clin. Invest. 72:677-684.
Haase et al., 1994, “Mapping of Bactericidal Epitopes on the P2 Porin Protein of Nontypeable Haemophilus influenzae,”Infection and Immunity62(9):3712-3722.
Troelstra et al., 1994, “Opsonic Antibodies to Outer Membrane Protein P2 of Nonencapsulated Haemophilus influenzae Are Strain Specific,”Infection and Immunity62(3):779-784.
Green et al., 1991, “The e (P4) Outer Membrane Protein of Haemophilus influenzae: Biologic Activity of Anti-e Serum and Cloning and Sequencing of the Structural Gene,”Infection and Immunity59(9):3191-3198.
Nelson et al., 1991, “Molecular Conservation of the P6 Outer Membrane Protein among Strains of Haemophilus influenzae: Analysis of Antigenic Determinants, Gene Sequences, and Restriction Fragment Length Polymorphisms,”Infection and Immunity59(8):2658-2663.
Deich et al., 1990, “Antigenic Conservation of the 15,000-Dalton Outer Membrane Lipoprotein PCP of Haemophilus influenzae and Biologic Activity of Anti-PCP Antisera,”Infection and Immunity58(10):3388-3393.
Green et al., 1993, “Evaluation of Mixtures of Purified Haemophilus influenzae Outer Membrane Proteins against Challenge with Nontypeable H. influenzae in the Chinchilla Otitis Media Model,”Infection and Immunity61(5):1950-1957.
Demaria et al., 1996, “Immunization with Outer Membrane Protein P6 from Nontypeable Haemophilus influenzae Induces Bactericidal Antibody and Affords Protection in the Chinchilla
Duffy Patricia A
GlaxoSmithKline Biologicals S.A.
Seed IP Law Group PLLC
LandOfFree
BASB205 polypeptides and polynucleotides from Haemophilus... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with BASB205 polypeptides and polynucleotides from Haemophilus..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and BASB205 polypeptides and polynucleotides from Haemophilus... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4243300